Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Funding for this research was provided by:
There was no external funding for writing this commentary.